Evaluating Whether Integration of Prognostic and Predictive Algorithms Into Routine Clinical Practice Effect Whether Oncologists Order Multigene Assays in Patients With Early Stage Breast Cancer

Sponsor
Ottawa Hospital Research Institute
Study ID
NCT04131933
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

A broad range of prognostic and predictive tools are available for patients with newly diagnosed early stage breast cancer. These range from free and publicly available mathematical algorithms, through to expensive genomic tests. It is not known how the use of these different scores affects physician decision making with respect to ordering genomic tests, nor how well these algorithms predict for the results of Oncotype DX ® in the real-world setting. This pragmatic study will help to answer these questions.

Key Dates

Start date
Mar 6, 2020
Status verified
Dec 2025
Primary completion
May 18, 2022
Completion
May 18, 2022

Study Design

Enrollment
602 participants (actual)

Primary Outcome Measure

Number of Participants With Oncotype DX Testing Ordered [ Time Frame: 12 Months ]

Related Studies